MP29-08 EPIGENETIC IDENTIFICATION OF IRF8 AS A FUNCTIONAL TUMOR SUPPRESSOR IN RENAL CELL CARCINAMA AND ITS ABERRANT PROMOTER METHYLATION IS ASSOCIATED WITH TUMORS¡¯ PROGNOSIS

zhang lian,zhang qian,li lili,su xianwei,tao qian,jin jie
DOI: https://doi.org/10.1016/j.juro.2014.02.750
2014-01-01
Abstract:You have accessJournal of UrologyKidney Cancer: Basic Research II1 Apr 2014MP29-08 EPIGENETIC IDENTIFICATION OF IRF8 AS A FUNCTIONAL TUMOR SUPPRESSOR IN RENAL CELL CARCINAMA AND ITS ABERRANT PROMOTER METHYLATION IS ASSOCIATED WITH TUMORS¡¯ PROGNOSIS Zhang Lian, Zhang Qian, Li Lili, Su XianWei, Tao Qian, and Jin Jie Zhang LianZhang Lian More articles by this author , Zhang QianZhang Qian More articles by this author , Li LiliLi Lili More articles by this author , Su XianWeiSu XianWei More articles by this author , Tao QianTao Qian More articles by this author , and Jin JieJin Jie More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2014.02.750AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES To explore the promoter methylation status of Interferon regulatory factor 8 (IRF8) and its potential tumor suppressor function in renal cell carcinoma (RCC), which further clarifies the effects of IRF8 on RCC tumorigenesis. METHODS IRF8 expression and methylation were detected by semi-quantitative RT-PCR and methylation specific PCR (MSP) in multiple RCC cell lines and primary tumors. We examined the cell cycle of IRF8-transfected RCC cell lines by flow cytometry method, assessed the colony formation ability of IRF8 by colony formation assay, and detected the invasion ability by wound healing assay. The target genes of IRF8 by quantitative PCR had been identified. RESULTS IRF8 was highly expressed in adjacent noncancerous region of human adult RCC tissue and greatly down-regulated or transcriptional silenced in RCC cell lines. The methylation specific PCR revealed that IRF8 promoter was methylated in 50% of RCC cell lines, and in 31.25% of renal primary tumors patients. The methylation of IRF8 was associated with tumour nuclear grade. The silencing of IRF8 in RCC cell lines, due to aberrant DNA methylation, could be reversed by pharmacologic demethylation reagent AZA. Ectopic expression of IRF8 inhibited colony formation and invasion ability of RCC cell lines (786-O, A498) and caused G2/M arrest . IRF8 involved in IFN-gamma-mediated apoptosis in RCC cells. We further found that IRF8 inhibited the expression of oncogenes, such as YAP1 and survivin, and upregulated the expression of tumor suppressor genes, such as P21, CASP1 and PTEN, specially in IFN-gamma treated tumor cells. CONCLUSIONS Our results indicated that IRF8 silenced by methylation is a frequent event in RCC, and its promoter methylation is associated with tumor nuclear grade. IFN-gamma enhance IRF8 exerting its tumor-suppressive function in RCC cells suggesting that IRF8 involved in RCC tumorigenesis. © 2014FiguresReferencesRelatedDetails Volume 191Issue 4SApril 2014Page: e307-e308 Advertisement Copyright & Permissions© 2014MetricsAuthor Information Zhang Lian More articles by this author Zhang Qian More articles by this author Li Lili More articles by this author Su XianWei More articles by this author Tao Qian More articles by this author Jin Jie More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...
What problem does this paper attempt to address?